U.S., Feb. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07393022) titled 'Bioequivalence Study of Levetiracetam 1500 mg Coated Granules in Healthy, Male Subjects' on Dec. 01, 2025.
Brief Summary: Pivotal, single-dose, randomized, open-label, two-period, two-sequence, two-treatment, single-centre, crossover, bioequivalence study of Levetiracetam 1500 mg coated granules in sachet formulations and Keppra (Levetiracetam) 2 x 750 mg film-coated tablet formulations in healthy male and female under fasting conditions.
Study Start Date: Dec. 17, 2025
Study Type: INTERVENTIONAL
Condition:
Pharmacokinetic Analysis
Bioequivalence
Health Adult Subjects
Intervention:
DRUG: Levetiracetam 1500 mg
coated granules, ...